[Malabsorption syndrome and intestinal pseudoobstruction in primary vascular and heart amyloidosis].
D000328:Adult; D000686:Amyloidosis / Q000150:complications* / Q000188:drug therapy / Q000276:immunology / Q000473:pathology; D000917:Antibody Formation; D000936:Antigen-Antibody Complex; D001379:Azathioprine / Q000627:therapeutic use; D002701:Chloramphenicol / Q000627:therapeutic use; D003545:Cysteine / Q000627:therapeutic use; D006331:Heart Diseases / Q000150:complications*; D006801:Humans; D007415:Intestinal Obstruction / Q000209:etiology*; D008286:Malabsorption Syndromes / Q000209:etiology*; D008297:Male; D008558:Melphalan / Q000627:therapeutic use; D010396:Penicillamine / Q000627:therapeutic use; D011241:Prednisone / Q000627:therapeutic use; D013997:Time Factors; D014652:Vascular Diseases / Q000150:complications*
D000936:Antigen-Antibody Complex; D002701:Chloramphenicol; D010396:Penicillamine; D003545:Cysteine; D001379:Azathioprine; D008558:Melphalan; D011241:Prednisone
Malabsorptionssyndrom und intestinale Pseudoobstruktion bie primärer Amyloidose der Gefässe und des Herzens